# Harnessing Microbiome-Mediated and Macrophage-Driven Mechanisms for Oral Wound Healing

**Authors:** Keerthi Priya Chinniampalayam Sekar, Bianca Schmiliver, Paige Elizabeth Pieterick, Tim Cha, Helly A. Patel, Hope Robinson, Prashant Kumar, David T. Wu, Rheinallt Jones, Steven Goudy

PMC · DOI: 10.3390/microorganisms14020330 · 2026-01-30

## TL;DR

This paper reviews how the oral microbiome and macrophages work together to promote fast and effective healing of mouth wounds.

## Contribution

The paper provides a synthesis of how the oral microbiome influences macrophage behavior during wound healing and explores potential microbiome-based therapies.

## Key findings

- Oral wounds heal quickly with minimal scarring despite microbial exposure.
- Macrophages switch from pro-inflammatory to anti-inflammatory states to aid healing.
- Microbiome-based strategies could modulate immune responses to improve wound repair.

## Abstract

Oral mucosa healing is a complex process that involves the innate wound healing system, including the coagulation cascade, extracellular matrix remodeling, immune cell responses, and fibroblast and epithelial responses, within the context of a dynamic resident microbiome. Unlike cutaneous wounds, oral wounds heal rapidly with minimal scarring despite constant exposure to diverse microbial communities, saliva, and mechanical stress. Emerging evidence highlights the critical interplay between microbiome-mediated signaling and macrophage plasticity in shaping wound outcomes, suggesting that similar mechanisms operate within the oral cavity. Inflammation is an essential component of wound repair, and its resolution is necessary to promote tissue remodeling and functional regeneration. Macrophages play a central role in this transition through phenotype switching from a pro-inflammatory (M1) to a pro-resolving, anti-inflammatory (M2) state. This review synthesizes current understanding of the oral microbiome’s influence on macrophage polarization across distinct stages of oral wound healing and examines microbial-based strategies that modulate the immune response to enhance repair. Significant knowledge gaps remain, including limited clinical translation, inter-individual variability in microbiome composition, and complete mechanistic insight into host–microbe immune interaction. Addressing these challenges enables the development of precision microbiome-based therapeutics that restore microbial balance, direct macrophage-driven regeneration, and improve outcomes in oral wounds and chronic inflammatory conditions.

## Full-text entities

- **Genes:** AIM2 (absent in melanoma 2) [NCBI Gene 9447] {aka PYHIN4}, IL12B (interleukin 12B) [NCBI Gene 3593] {aka CLMF, CLMF2, IL-12B, IMD28, IMD29, NKSF}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, STATH (statherin) [NCBI Gene 6779] {aka STR}, TGFA (transforming growth factor alpha) [NCBI Gene 7039] {aka TFGA}, EGF (epidermal growth factor) [NCBI Gene 1950] {aka HOMG4, URG}, NOS2 (nitric oxide synthase 2) [NCBI Gene 4843] {aka HEP-NOS, INOS, NOS, NOS2A}, STAT1 (signal transducer and activator of transcription 1) [NCBI Gene 6772] {aka CANDF7, IMD31A, IMD31B, IMD31C, ISGF-3, STAT91}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, IL1A (interleukin 1 alpha) [NCBI Gene 3552] {aka IL-1 alpha, IL-1A, IL1, IL1-ALPHA, IL1F1}, TLR2 (toll like receptor 2) [NCBI Gene 7097] {aka CD282, TIL4}, CCR7 (C-C motif chemokine receptor 7) [NCBI Gene 1236] {aka BLR2, CC-CKR-7, CCR-7, CD197, CDw197, CMKBR7}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, CXCL1 (C-X-C motif chemokine ligand 1) [NCBI Gene 2919] {aka FSP, GRO1, GROa, MGSA, MGSA-a, NAP-3}, CXCL3 (C-X-C motif chemokine ligand 3) [NCBI Gene 2921] {aka CINC-2b, GRO3, GROg, MIP-2b, MIP2B, SCYB3}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, CD163 (CD163 molecule) [NCBI Gene 9332] {aka M130, MM130, SCARI1}, KRT12 (keratin 12) [NCBI Gene 3859] {aka K12, MECD1}, NGF (nerve growth factor) [NCBI Gene 4803] {aka Beta-NGF, HSAN5, NGFB}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, IGF1 (insulin like growth factor 1) [NCBI Gene 3479] {aka IGF, IGF-I, IGFI, MGF}, IL13 (interleukin 13) [NCBI Gene 3596] {aka IL-13, P600}, CD274 (CD274 molecule) [NCBI Gene 29126] {aka ADMIO5, B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1}, IFNB1 (interferon beta 1) [NCBI Gene 3456] {aka IFB, IFF, IFN-beta, IFNB}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, CX3CR1 (C-X3-C motif chemokine receptor 1) [NCBI Gene 1524] {aka CCRL1, CMKBRL1, CMKDR1, GPR13, GPRV28, V28}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, PDCD1LG2 (programmed cell death 1 ligand 2) [NCBI Gene 80380] {aka B7DC, Btdc, CD273, PD-L2, PDCD1L2, PDL2}, FN1 (fibronectin 1) [NCBI Gene 2335] {aka CIG, ED-B, FINC, FN, FNZ, GFND}, F3 (coagulation factor III, tissue factor) [NCBI Gene 2152] {aka CD142, TF, TFA}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, CSF2 (colony stimulating factor 2) [NCBI Gene 1437] {aka CSF, GMCSF}, CXCL5 (C-X-C motif chemokine ligand 5) [NCBI Gene 6374] {aka ENA-78, SCYB5}
- **Diseases:** oral disease (MESH:D009059), obesity (MESH:D009765), bleeding (MESH:D006470), venous ulcers (MESH:D014647), metabolic disorders (MESH:D008659), burns (MESH:D002056), systemic diseases (MESH:D034721), platelet aggregation (MESH:D001791), fibrosis (MESH:D005355), oral mucosal ulcers (MESH:D019226), Wounds (MESH:D014947), periodontal wounds (MESH:D010518), Inflammation (MESH:D007249), antibiotic-associated diarrhea (MESH:D004761), diabetic oral wounds (MESH:D003920), Dysbiosis (MESH:D064806), opportunistic infections (MESH:D009894), Alzheimer's disease (MESH:D000544), swelling (MESH:D004487), blood loss (MESH:D016063), vascular disruption (MESH:D019958), inflammatory bowel diseases (MESH:D015212), IBS (MESH:D043183), type 2 diabetes (MESH:D003924), allergic (MESH:D004342), Oral (MESH:D020820), endodontic infections (MESH:D011671), atopic dermatitis (MESH:D003876), fistula (MESH:D005402), periodontal disease (MESH:D010510), chronic (MESH:D002908), ulcerative colitis (MESH:D003093), tissue injury (MESH:D017695), rheumatoid arthritis (MESH:D001172), pressure ulcers (MESH:D003668), diabetic oral ulcers (MESH:D017719), dental caries (MESH:D003731), Clostridium difficile colitis (MESH:D003015), atherosclerotic cardiovascular disease (MESH:D050197), gastrointestinal disorders (MESH:D005767), Crohn's disease (MESH:D003424), infection (MESH:D007239)
- **Chemicals:** nitric oxide (MESH:D009569), alginate (MESH:D000464), chitosan (MESH:D048271), PEG (MESH:D011092), reuterin (MESH:C047158), Lipoteichoic acids (MESH:C009900), LPS (MESH:D008070), SCFAs (MESH:D005232), ROS (MESH:D017382), lipoxins (MESH:D044045), OMV (-)
- **Species:** Enterococcus faecalis (species) [taxon 1351], Actinomyces (genus) [taxon 1654], Streptococcus salivarius K12 (strain) [taxon 1200793], Candida albicans (species) [taxon 5476], Actinomyces naeslundii (species) [taxon 1655], Streptococcus mutans (species) [taxon 1309], Escherichia coli (E. coli, species) [taxon 562], Mus musculus (house mouse, species) [taxon 10090], Human papillomavirus (species) [taxon 10566], Human betaherpesvirus 5 (no rank) [taxon 10359], Fusobacterium nucleatum (species) [taxon 851], Streptococcus salivarius (species) [taxon 1304], gut metagenome (species) [taxon 749906], Bifidobacterium breve (species) [taxon 1685], Limosilactobacillus reuteri (species) [taxon 1598], Porphyromonas gingivalis (species) [taxon 837], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Bacteroides fragilis (species) [taxon 817], human gammaherpesvirus 4 (Epstein Barr virus, no rank) [taxon 10376], Staphylococcus (genus) [taxon 1279], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** HT29 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0320), Mono-Mac-6 — Homo sapiens (Human), Adult acute monocytic leukemia, Cancer cell line (CVCL_1426), THP-1 — Homo sapiens (Human), Childhood acute monocytic leukemia, Cancer cell line (CVCL_0006)

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12943451/full.md

---
Source: https://tomesphere.com/paper/PMC12943451